Seelos Therapeutics Inc (SEELQ)
0.31
-0.18
(-37.37%)
USD |
OTCM |
Nov 22, 15:01
Seelos Therapeutics Total Liabilities (Quarterly): 30.51M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 30.51M |
March 31, 2024 | 36.72M |
December 31, 2023 | 38.93M |
September 30, 2023 | 36.63M |
June 30, 2023 | 59.07M |
March 31, 2023 | 44.30M |
December 31, 2022 | 33.36M |
September 30, 2022 | 32.63M |
June 30, 2022 | 26.44M |
March 31, 2022 | 25.06M |
December 31, 2021 | 26.18M |
September 30, 2021 | 8.034M |
June 30, 2021 | 7.611M |
March 31, 2021 | 16.61M |
December 31, 2020 | 14.92M |
September 30, 2020 | 3.186M |
June 30, 2020 | 4.053M |
March 31, 2020 | 7.406M |
December 31, 2019 | 11.10M |
September 30, 2019 | 5.863M |
June 30, 2019 | 5.34M |
March 31, 2019 | 9.307M |
December 31, 2018 | 1.188M |
September 30, 2018 | 1.451M |
June 30, 2018 | 1.938M |
Date | Value |
---|---|
March 31, 2018 | 1.732M |
December 31, 2017 | 2.335M |
September 30, 2017 | 2.504M |
June 30, 2017 | 2.243M |
March 31, 2017 | 4.511M |
December 31, 2016 | 12.22M |
September 30, 2016 | 15.95M |
June 30, 2016 | 15.61M |
March 31, 2016 | 17.28M |
December 31, 2015 | 17.72M |
September 30, 2015 | 17.51M |
June 30, 2015 | 14.64M |
March 31, 2015 | 17.97M |
December 31, 2014 | 12.89M |
September 30, 2014 | 7.80M |
June 30, 2014 | 8.438M |
March 31, 2014 | 16.10M |
December 31, 2013 | 12.34M |
September 30, 2013 | 10.35M |
June 30, 2013 | 13.53M |
March 31, 2013 | 17.24M |
December 31, 2012 | 17.26M |
September 30, 2012 | 17.21M |
June 30, 2012 | 12.36M |
March 31, 2012 | 11.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.186M
Minimum
Sep 2020
59.07M
Maximum
Jun 2023
24.35M
Average
26.18M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
Cassava Sciences Inc | 57.11M |
Cara Therapeutics Inc | 50.62M |
Citius Pharmaceuticals Inc | 10.81M |
Moleculin Biotech Inc | 15.92M |
180 Life Sciences Corp | 6.736M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.381M |
Shareholders Equity (Quarterly) | -28.13M |